This home-based study is a randomized (1:1) placebo-controlled trial of a single infusion of zoledronic acid-5 mg (ZA) for the prevention of fractures in men and women aged 60 years and older with Parkinson's disease and parkinsonism with at least 2 years of follow-u...
- Osteoporosis
- Parkinson Disease
- Dementia
- Multiple System Atrophy
- Shy-Drager Syndrome
- Parkinsonian Disorders
- Supranuclear Palsy, Progressive
- Lewy Body Disease
- Atrophy
Age: 60 years - 66+
Gender: All